{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T20:12:01Z","timestamp":1792699921777,"version":"4.5.0"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,10,16]],"date-time":"2021-10-16T00:00:00Z","timestamp":1634342400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,10,16]],"date-time":"2021-10-16T00:00:00Z","timestamp":1634342400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Divers"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1007\/s11030-021-10323-2","type":"journal-article","created":{"date-parts":[[2021,10,16]],"date-time":"2021-10-16T16:27:10Z","timestamp":1634401630000},"page":"2159-2174","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Discovery of inhibitors targeting protein tyrosine phosphatase 1B using a\u00a0combined virtual screening approach"],"prefix":"10.1007","volume":"26","author":[{"given":"Dan","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4213-2808","authenticated-orcid":false,"given":"Shijun","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,16]]},"reference":[{"issue":"2","key":"10323_CR1","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/nrendo.2017.151","volume":"14","author":"Y Zheng","year":"2018","unstructured":"Zheng Y, Ley SH, Hu FB (2018) Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocrinol 14(2):88\u201398. https:\/\/doi.org\/10.1038\/nrendo.2017.151","journal-title":"Nat Rev Endocrinol"},{"issue":"11","key":"10323_CR2","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.3390\/cells9112465","volume":"9","author":"S Gheibi","year":"2020","unstructured":"Gheibi S, Singh T, da Cunha JPMCM, Fex M, Mulder H (2020) Insulin\/glucose-responsive cells derived from induced pluripotent stem cells: disease modeling and treatment of diabetes. Cells 9(11):2465. https:\/\/doi.org\/10.3390\/cells9112465","journal-title":"Cells-Basel"},{"issue":"7","key":"10323_CR3","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1038\/nm.4350","volume":"23","author":"MP Czech","year":"2017","unstructured":"Czech MP (2017) Insulin action and resistance in obesity and type 2 diabetes. Nat Med 23(7):804\u2013814. https:\/\/doi.org\/10.1038\/nm.4350","journal-title":"Nat Med"},{"issue":"9","key":"10323_CR4","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1080\/13543776.2019.1655542","volume":"29","author":"H Hussain","year":"2019","unstructured":"Hussain H, Green IR, Abbas G, Adekenov SM, Hussain W, Ali I (2019) Protein tyrosine phosphatase 1B (PTP1B) inhibitors as potential anti-diabetes agents: patent review (2015\u20132018). Expert Opin Ther Pat 29(9):689\u2013702. https:\/\/doi.org\/10.1080\/13543776.2019.1655542","journal-title":"Expert Opin Ther Pat"},{"key":"10323_CR5","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.ejmech.2018.04.061","volume":"152","author":"N Kerru","year":"2018","unstructured":"Kerru N, Singh-Pillay A, Awolade P, Singh P (2018) Current anti-diabetic agents and their molecular targets: a review. Eur J Med Chem 152:436\u2013488. https:\/\/doi.org\/10.1016\/j.ejmech.2018.04.061","journal-title":"Eur J Med Chem"},{"issue":"10","key":"10323_CR6","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1517\/13543776.2014.947268","volume":"24","author":"AK Tamrakar","year":"2014","unstructured":"Tamrakar AK, Maurya CK, Rai AK (2014) PTP1B inhibitors for type 2 diabetes treatment: a patent review (2011\u20132014). Expert Opin Ther Pat 24(10):1101\u20131115. https:\/\/doi.org\/10.1517\/13543776.2014.947268","journal-title":"Expert Opin Ther Pat"},{"issue":"6","key":"10323_CR7","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.cell.2004.05.018","volume":"117","author":"A Alonso","year":"2004","unstructured":"Alonso A, Sasin J, Bottini N, Friedberg I, Friedberg I, Osterman A, Godzik A, Hunter T, Dixon J, Mustelin T (2004) Protein tyrosine phosphatases in the human genome. Cell 117(6):699\u2013711. https:\/\/doi.org\/10.1016\/j.cell.2004.05.018","journal-title":"Cell"},{"issue":"60","key":"10323_CR8","doi-asserted-by":"publisher","first-page":"48822","DOI":"10.1039\/C5RA01754H","volume":"5","author":"L-J Wang","year":"2015","unstructured":"Wang L-J, Jiang B, Wu N, Wang S-Y, Shi D-Y (2015) Natural and semisynthetic protein tyrosine phosphatase 1B (PTP1B) inhibitors as anti-diabetic agents. RSC Adv 5(60):48822\u201348834. https:\/\/doi.org\/10.1039\/C5RA01754H","journal-title":"RSC Adv"},{"issue":"6865","key":"10323_CR9","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1038\/414821a","volume":"414","author":"DE Moller","year":"2001","unstructured":"Moller DE (2001) New drug targets for type 2 diabetes and the metabolic syndrome. Nature 414(6865):821\u2013827. https:\/\/doi.org\/10.1038\/414821a","journal-title":"Nature"},{"issue":"6","key":"10323_CR10","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1046\/j.1365-2796.2002.00992.x","volume":"251","author":"O Ukkola","year":"2002","unstructured":"Ukkola O, Santaniemi M (2002) Protein tyrosine phosphatase 1B: a new target for the treatment of obesity and associated co-morbidities. J Intern Med 251(6):467\u2013475. https:\/\/doi.org\/10.1046\/j.1365-2796.2002.00992.x","journal-title":"J Intern Med"},{"issue":"1","key":"10323_CR11","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1124\/mol.104.005553","volume":"67","author":"DV Erbe","year":"2005","unstructured":"Erbe DV, Wang SY, Zhang YL, Harding K, Kung L, Tam M, Stolz L, Xing YZ, Furey S, Qadri A, Klaman LD, Tobin JF (2005) Ertiprotafib improves glycemic control and lowers lipids via multiple mechanisms. Mol Pharmacol 67(1):69\u201377. https:\/\/doi.org\/10.1124\/mol.104.005553","journal-title":"Mol Pharmacol"},{"issue":"8","key":"10323_CR12","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1038\/oby.2009.444","volume":"18","author":"KA Lantz","year":"2010","unstructured":"Lantz KA, Hart SGE, Planey SL, Roitman MF, Ruiz-White IA, Wolfe HR, McLane MP (2010) Inhibition of PTP1B by trodusquemine (MSI-1436) causes fat-specific weight loss in diet-induced obese mice. Obesity 18(8):1516\u20131523. https:\/\/doi.org\/10.1038\/oby.2009.444","journal-title":"Obesity"},{"issue":"16","key":"10323_CR13","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.2174\/138161210791209027","volume":"16","author":"LM Scott","year":"2010","unstructured":"Scott LM, Lawrence HR, Sebti SM, Lawrence NJ, Wu J (2010) Targeting protein tyrosine phosphatases for anticancer drug discovery. Curr Pharm Design 16(16):1843\u20131862. https:\/\/doi.org\/10.2174\/138161210791209027","journal-title":"Curr Pharm Design"},{"issue":"14","key":"10323_CR14","doi-asserted-by":"publisher","first-page":"2225","DOI":"10.1089\/ars.2013.5710","volume":"20","author":"JL Low","year":"2014","unstructured":"Low JL, Chai CLL, Yao SQ (2014) Bidentate inhibitors of protein tyrosine phosphatases. Antioxid Redox Sign 20(14):2225\u20132250. https:\/\/doi.org\/10.1089\/ars.2013.5710","journal-title":"Antioxid Redox Sign"},{"issue":"5152","key":"10323_CR15","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1126\/science.8128219","volume":"263","author":"D Barford","year":"1994","unstructured":"Barford D, Flint AJ, Tonks NK (1994) Crystal-structure of human protein-tyrosine-phosphatase 1b. Science 263(5152):1397\u20131404. https:\/\/doi.org\/10.1126\/science.8128219","journal-title":"Science"},{"issue":"25","key":"10323_CR16","doi-asserted-by":"publisher","first-page":"13420","DOI":"10.1073\/pnas.94.25.13420","volume":"94","author":"YA Puius","year":"1997","unstructured":"Puius YA, Zhao Y, Sullivan M, Lawrence DS, Almo SC, Zhang ZY (1997) Identification of a second aryl phosphate-binding site in protein-tyrosine phosphatase 1B: a paradigm for inhibitor design. P Natl Acad Sci USA 94(25):13420\u201313425. https:\/\/doi.org\/10.1073\/pnas.94.25.13420","journal-title":"P Natl Acad Sci USA"},{"issue":"29","key":"10323_CR17","doi-asserted-by":"publisher","first-page":"9043","DOI":"10.1021\/bi0259554","volume":"41","author":"E Asante-Appiah","year":"2002","unstructured":"Asante-Appiah E, Patel S, Dufresne C, Roy P, Wang QP, Patel V, Friesen RW, Ramachandran C, Becker JW, Leblanc Y, Kennedy BP, Scapin G (2002) The structure of PTP-1B in complex with a peptide inhibitor reveals an alternative binding mode for bisphosphonates. Biochemistry-US 41(29):9043\u20139051. https:\/\/doi.org\/10.1021\/bi0259554","journal-title":"Biochemistry-US"},{"issue":"8","key":"10323_CR18","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1038\/nsmb803","volume":"11","author":"C Wiesmann","year":"2004","unstructured":"Wiesmann C, Barr KJ, Kung J, Zhu J, Erlanson DA, Shen W, Fahr BJ, Zhong M, Taylor L, Randal M, McDowell RS, Hansen SK (2004) Allosteric inhibition of protein tyrosine phosphatase 1B. Nat Struct Mol Biol 11(8):730\u2013737. https:\/\/doi.org\/10.1038\/nsmb803","journal-title":"Nat Struct Mol Biol"},{"key":"10323_CR19","doi-asserted-by":"publisher","unstructured":"He R, Zeng L-F, He Y, Zhang Z-Y (2012) Chapter 6 recent advances in PTP1B inhibitor development for the treatment of type 2 diabetes and obesity. In: Jones RM (ed) New therapeutic strategies for type 2 diabetes: small molecule approaches. The Royal Society of Chemistry, pp 142\u2013176. https:\/\/doi.org\/10.1039\/9781849735322-00142","DOI":"10.1039\/9781849735322-00142"},{"issue":"1","key":"10323_CR20","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1002\/pro.3784","volume":"29","author":"SD Wierbowski","year":"2020","unstructured":"Wierbowski SD, Wingert BM, Zheng J, Camacho CJ (2020) Cross-docking benchmark for automated pose and ranking prediction of ligand binding. Protein Sci 29(1):298\u2013305. https:\/\/doi.org\/10.1002\/pro.3784","journal-title":"Protein Sci"},{"issue":"1","key":"10323_CR21","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1093\/nar\/28.1.235","volume":"28","author":"HM Berman","year":"2000","unstructured":"Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE (2000) The protein data bank. Nucleic Acids Res 28(1):235\u2013242. https:\/\/doi.org\/10.1093\/nar\/28.1.235","journal-title":"Nucleic Acids Res"},{"issue":"19","key":"10323_CR22","doi-asserted-by":"publisher","first-page":"5642","DOI":"10.1021\/bi002865v","volume":"40","author":"JE Bleasdale","year":"2001","unstructured":"Bleasdale JE, Ogg D, Palazuk BJ, Jacob CS, Swanson ML, Wang XY, Thompson DP, Conradi RA, Mathews WR, Laborde AL, Stuchly CW, Heijbel A, Bergdahl K, Bannow CA, Smith CW, Svensson C, Liljebris C, Schostarez HJ, May PD, Stevens FC, Larsen SD (2001) Small molecule peptidomimetics containing a novel phosphotyrosine bioisostere inhibit protein tyrosine phosphatase 1B and augment insulin actions. Biochemistry-US 40(19):5642\u20135654. https:\/\/doi.org\/10.1021\/bi002865v","journal-title":"Biochemistry-US"},{"issue":"49","key":"10323_CR23","doi-asserted-by":"publisher","first-page":"14812","DOI":"10.1021\/bi011389l","volume":"40","author":"LF Iversen","year":"2001","unstructured":"Iversen LF, Andersen HS, Moller KB, Olsen OH, Peters GH, Branner S, Mortensen SB, Hansen TK, Lau J, Ge Y, Holsworth DD, Newman NJ, Moller NPH (2001) Steric hindrance as a basis for structure-based design of selective inhibitors of protein-tyrosine phosphatases. Biochemistry-US 40(49):14812\u201314820. https:\/\/doi.org\/10.1021\/bi011389l","journal-title":"Biochemistry-US"},{"issue":"14","key":"10323_CR24","doi-asserted-by":"publisher","first-page":"4087","DOI":"10.1021\/ja0296733","volume":"125","author":"BG Szczepankiewicz","year":"2003","unstructured":"Szczepankiewicz BG, Liu G, Hajduk PJ, Abad-Zapatero C, Pei ZH, Xin ZL, Lubben TH, Trevillyan JM, Stashko MA, Ballaron SJ, Liang H, Huang F, Hutchins CW, Fesik SW, Jirousek MR (2003) Discovery of a potent, selective protein tyrosine phosphatase 1B inhibitor using a linked-fragment strategy. J Am Chem Soc 125(14):4087\u20134096. https:\/\/doi.org\/10.1021\/ja0296733","journal-title":"J Am Chem Soc"},{"issue":"11","key":"10323_CR25","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1016\/s0960-894x(03)00302-0","volume":"13","author":"ZL Xin","year":"2003","unstructured":"Xin ZL, Oost TK, Abad-Zapatero C, Hajduk PJ, Pei ZH, Szczepankiewicz BG, Hutchins CW, Ballaron SJ, Stashko MA, Lubben T, Trevillyan JM, Jirousek MR, Liu G (2003) Potent, selective inhibitors of protein tyrosine phosphatase 1B. Bioorg Med Chem Lett 13(11):1887\u20131890. https:\/\/doi.org\/10.1016\/s0960-894x(03)00302-0","journal-title":"Bioorg Med Chem Lett"},{"issue":"11","key":"10323_CR26","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1021\/jm0205696","volume":"46","author":"G Liu","year":"2003","unstructured":"Liu G, Szczepankiewicz BG, Pei ZH, Janowick DA, Xin ZL, Hajduk PJ, Abad-Zapatero C, Liang H, Hutchins CW, Fesik SW, Ballaron SJ, Stashko MA, Lubben T, Mika AK, Zinker BA, Trevillyan JM, Jirousek MR (2003) Discovery and structure-activity relationship of oxalylarylaminobenzoic acids as inhibitors of protein tyrosine phosphatase 1B. J Med Chem 46(11):2093\u20132103. https:\/\/doi.org\/10.1021\/jm0205696","journal-title":"J Med Chem"},{"issue":"16","key":"10323_CR27","doi-asserted-by":"publisher","first-page":"3437","DOI":"10.1021\/jm034088d","volume":"46","author":"G Liu","year":"2003","unstructured":"Liu G, Xin ZL, Liang H, Abad-Zapatero C, Hajduk PJ, Janowick DA, Szczepankiewicz BG, Pei ZH, Hutchins CW, Ballaron SJ, Stashko MA, Lubben TH, Berg CE, Rondinone CM, Trevillyan JM, Jirousek MR (2003) Selective protein tyrosine phosphatase 1B inhibitors: targeting the second phosphotyrosine binding site with non-carboxylic acid-containing ligands. J Med Chem 46(16):3437\u20133440. https:\/\/doi.org\/10.1021\/jm034088d","journal-title":"J Med Chem"},{"issue":"14","key":"10323_CR28","doi-asserted-by":"publisher","first-page":"12406","DOI":"10.1074\/jbc.M212491200","volume":"278","author":"JP Sun","year":"2003","unstructured":"Sun JP, Fedorov AA, Lee SY, Guo XL, Shen K, Lawrence DS, Almo SC, Zhang ZY (2003) Crystal structure of PTP1B complexed with a potent and selective bidentate inhibitor. J Biol Chem 278(14):12406\u201312414. https:\/\/doi.org\/10.1074\/jbc.M212491200","journal-title":"J Biol Chem"},{"issue":"22","key":"10323_CR29","doi-asserted-by":"publisher","first-page":"5543","DOI":"10.1016\/j.bmcl.2004.08.063","volume":"14","author":"HY Zhao","year":"2004","unstructured":"Zhao HY, Liu G, Xin ZL, Serby MD, Pei ZH, Szczepankiewicz BG, Hajduk PJ, Abad-Zapatero C, Hutchins CW, Lubben TH, Ballaron SJ, Haasch DL, Kaszubska W, Rondinone CM, Trevillyan JM, Jirousek MR (2004) Isoxazole carboxylic acids as protein tyrosine phosphatase 1B (PTP1B) inhibitors. Bioorg Med Chem Lett 14(22):5543\u20135546. https:\/\/doi.org\/10.1016\/j.bmcl.2004.08.063","journal-title":"Bioorg Med Chem Lett"},{"issue":"7","key":"10323_CR30","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.1016\/j.bmc.2005.11.005","volume":"14","author":"AF Moretto","year":"2006","unstructured":"Moretto AF, Kirincich SJ, Xu WX, Smith MJ, Wan ZK, Wilson DP, Follows BC, Binnun E, Joseph-McCarthy D, Foreman K, Erbe DV, Zhang YL, Tam SK, Tam SY, Lee J (2006) Bicyclic and tricyclic thiophenes as protein tyrosine phosphatase 1B inhibitors. Bioorgan Med Chem 14(7):2162\u20132177. https:\/\/doi.org\/10.1016\/j.bmc.2005.11.005","journal-title":"Bioorgan Med Chem"},{"issue":"43","key":"10323_CR31","doi-asserted-by":"publisher","first-page":"32784","DOI":"10.1074\/jbc.M606873200","volume":"281","author":"PJ Ala","year":"2006","unstructured":"Ala PJ, Gonneville L, Hillman MC, Becker-Pasha M, Wei M, Reid BG, Klabe R, Yue EW, Wayland B, Douty B, Polam P, Wasserman Z, Bower M, Combs AP, Burn TC, Hollis GF, Wynn R (2006) Structural basis for inhibition of protein-tyrosine phosphatase 1B by isothiazolidinone heterocyclic phosphonate mimetics. J Biol Chem 281(43):32784\u201332795. https:\/\/doi.org\/10.1074\/jbc.M606873200","journal-title":"J Biol Chem"},{"issue":"49","key":"10323_CR32","doi-asserted-by":"publisher","first-page":"38013","DOI":"10.1074\/jbc.M607913200","volume":"281","author":"PJ Ala","year":"2006","unstructured":"Ala PJ, Gonneville L, Hillman M, Becker-Pasha M, Yue EW, Douty B, Wayland B, Polam P, Crawley ML, McLaughlin E, Sparks RB, Glass B, Takvorian A, Combs AP, Burn TC, Hollis GF, Wynn R (2006) Structural insights into the design of nonpeptidic isothiazolidinone-containing inhibitors of protein-tyrosine phosphatase 1B. J Biol Chem 281(49):38013\u201338021. https:\/\/doi.org\/10.1074\/jbc.M607913200","journal-title":"J Biol Chem"},{"issue":"18","key":"10323_CR33","doi-asserted-by":"publisher","first-page":"4941","DOI":"10.1016\/j.bmcl.2006.06.051","volume":"16","author":"ZK Wan","year":"2006","unstructured":"Wan ZK, Lee J, Xu WX, Erbe DV, Joseph-McCarthy D, Follows BC, Zhang YL (2006) Monocyclic thiophenes as protein tyrosine phosphatase 1B inhibitors: capturing interactions with Asp48. Bioorg Med Chem Lett 16(18):4941\u20134945. https:\/\/doi.org\/10.1016\/j.bmcl.2006.06.051","journal-title":"Bioorg Med Chem Lett"},{"issue":"10","key":"10323_CR34","doi-asserted-by":"publisher","first-page":"2913","DOI":"10.1016\/j.bmcl.2007.02.043","volume":"17","author":"ZK Wan","year":"2007","unstructured":"Wan ZK, Follows B, Kirincich S, Wilson D, Binnun E, Xu WX, Joseph-McCarthy D, Wu JJ, Smith M, Zhang YL, Tam M, Erbe D, Tam S, Saiah E, Lee J (2007) Probing acid replacements of thiophene PTP1B inhibitors. Bioorg Med Chem Lett 17(10):2913\u20132920. https:\/\/doi.org\/10.1016\/j.bmcl.2007.02.043","journal-title":"Bioorg Med Chem Lett"},{"issue":"19","key":"10323_CR35","doi-asserted-by":"publisher","first-page":"4681","DOI":"10.1021\/jm0702478","volume":"50","author":"DP Wilson","year":"2007","unstructured":"Wilson DP, Wan ZK, Xu WX, Kirincich SJ, Follows BC, Joseph-McCarthy D, Foreman K, Moretto A, Wu J, Zhu M, Binnun E, Zhang YL, Tam M, Erbe DV, Tobin J, Xu X, Leung L, Shilling A, Tam SY, Mansour TS, Lee J (2007) Structure-based optimization of protein tyrosine phosphatase 1B inhibitors: From the active site to the second phosphotyrosine binding site. J Med Chem 50(19):4681\u20134698. https:\/\/doi.org\/10.1021\/jm0702478","journal-title":"J Med Chem"},{"issue":"10","key":"10323_CR36","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1002\/cmdc.200800188","volume":"3","author":"ZK Wan","year":"2008","unstructured":"Wan ZK, Lee JB, Hotchandani R, Moretto A, Binnun E, Wilson DP, Kirincich SJ, Follows BC, Ipek M, Xu WX, Joseph-McCarthy D, Zhang YL, Tam M, Erbe DV, Tobin JF, Li W, Tam SY, Mansour TS, Wu JJ (2008) Structure-based optimization of protein tyrosine phosphatase-1 B inhibitors: capturing interactions with arginine 24. ChemMedChem 3(10):1525\u20131529. https:\/\/doi.org\/10.1002\/cmdc.200800188","journal-title":"ChemMedChem"},{"issue":"8","key":"10323_CR37","doi-asserted-by":"publisher","first-page":"3163","DOI":"10.1172\/JCI80323","volume":"125","author":"N Krishnan","year":"2015","unstructured":"Krishnan N, Krishnan K, Connors CR, Choy MS, Page R, Peti W, Van Aelst L, Shea SD, Tonks NK (2015) PTP1B inhibition suggests a therapeutic strategy for Rett syndrome. J Clin Invest 125(8):3163\u20133177. https:\/\/doi.org\/10.1172\/JCI80323","journal-title":"J Clin Invest"},{"issue":"6","key":"10323_CR38","doi-asserted-by":"publisher","first-page":"3:1","DOI":"10.1147\/jrd.2018.2883977","volume":"62","author":"DR Koes","year":"2018","unstructured":"Koes DR (2018) The Pharmit backend: a computer systems approach to enabling interactive online drug discovery. IBM J Res Dev  62(6):3:1\u20133:6. https:\/\/doi.org\/10.1147\/jrd.2018.2883977","journal-title":"IBM J Res Dev"},{"issue":"14","key":"10323_CR39","doi-asserted-by":"publisher","first-page":"6582","DOI":"10.1021\/jm300687e","volume":"55","author":"MM Mysinger","year":"2012","unstructured":"Mysinger MM, Carchia M, Irwin JJ, Shoichet BK (2012) Directory of useful decoys, enhanced (DUD-E): better ligands and decoys for better benchmarking. J Med Chem 55(14):6582\u20136594. https:\/\/doi.org\/10.1021\/jm300687e","journal-title":"J Med Chem"},{"issue":"12","key":"10323_CR40","doi-asserted-by":"publisher","first-page":"3163","DOI":"10.1021\/ci400429g","volume":"53","author":"YM Zhang","year":"2013","unstructured":"Zhang YM, Yang SY, Jiao Y, Liu HC, Yuan HL, Lu S, Ran T, Yao SH, Ke ZP, Xu JX, Xiong X, Chen YD, Lu T (2013) An integrated virtual screening approach for VEGFR-2 nhibitors. J Chem Inf Model 53(12):3163\u20133177. https:\/\/doi.org\/10.1021\/ci400429g","journal-title":"J Chem Inf Model"},{"issue":"4","key":"10323_CR41","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1021\/ci200617d","volume":"52","author":"A Hamza","year":"2012","unstructured":"Hamza A, Wei NN, Zhan CG (2012) Ligand-based virtual screening approach using a new scoring function. J Chem Inf Model 52(4):963\u2013974. https:\/\/doi.org\/10.1021\/ci200617d","journal-title":"J Chem Inf Model"},{"issue":"8","key":"10323_CR42","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.patrec.2005.10.010","volume":"27","author":"T Fawcett","year":"2006","unstructured":"Fawcett T (2006) An introduction to ROC analysis. Pattern Recogn Lett 27(8):861\u2013874. https:\/\/doi.org\/10.1016\/j.patrec.2005.10.010","journal-title":"Pattern Recogn Lett"},{"issue":"1","key":"10323_CR43","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1148\/radiology.143.1.7063747","volume":"143","author":"JA Hanley","year":"1982","unstructured":"Hanley JA, Mcneil BJ (1982) The meaning and use of the area under a receiver operating characteristic (Roc) curve. Radiology 143(1):29\u201336. https:\/\/doi.org\/10.1148\/radiology.143.1.7063747","journal-title":"Radiology"},{"key":"10323_CR44","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-12-77","author":"X Robin","year":"2011","unstructured":"Robin X, Turck N, Hainard A, Tiberti N, Lisacek F, Sanchez JC, Muller M (2011) pROC: an open-source package for R and S plus to analyze and compare ROC curves. BMC Bioinformatics. https:\/\/doi.org\/10.1186\/1471-2105-12-77","journal-title":"BMC Bioinformatics"},{"issue":"15","key":"10323_CR45","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1002\/jcc.23905","volume":"36","author":"WJ Allen","year":"2015","unstructured":"Allen WJ, Balius TE, Mukherjee S, Brozell SR, Moustakas DT, Lang PT, Case DA, Kuntz ID, Rizzo RC (2015) DOCK 6: impact of new features and current docking performance. J Comput Chem 36(15):1132\u20131156. https:\/\/doi.org\/10.1002\/jcc.23905","journal-title":"J Comput Chem"},{"issue":"2","key":"10323_CR46","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/jcc.21334","volume":"31","author":"O Trott","year":"2010","unstructured":"Trott O, Olson AJ (2010) Software news and update autoDock vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem 31(2):455\u2013461. https:\/\/doi.org\/10.1002\/jcc.21334","journal-title":"J Comput Chem"},{"issue":"11","key":"10323_CR47","doi-asserted-by":"publisher","first-page":"2493","DOI":"10.1016\/j.bmcl.2014.04.017","volume":"24","author":"HT Zhao","year":"2014","unstructured":"Zhao HT, Gartenmann L, Dong J, Spiliotopoulos D, Caflisch A (2014) Discovery of BRD4 bromodomain inhibitors by fragment-based high-throughput docking. Bioorg Med Chem Lett 24(11):2493\u20132496. https:\/\/doi.org\/10.1016\/j.bmcl.2014.04.017","journal-title":"Bioorg Med Chem Lett"},{"issue":"8","key":"10323_CR48","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1021\/ci300604z","volume":"53","author":"DR Koes","year":"2013","unstructured":"Koes DR, Baumgartner MP, Camacho CJ (2013) Lessons learned in empirical scoring with smina from the CSAR 2011 benchmarking exercise. J Chem Inf Model 53(8):1893\u20131904. https:\/\/doi.org\/10.1021\/ci300604z","journal-title":"J Chem Inf Model"},{"issue":"15","key":"10323_CR49","doi-asserted-by":"publisher","first-page":"4553","DOI":"10.1021\/jm8001668","volume":"51","author":"S Zhong","year":"2008","unstructured":"Zhong S, Chen X, Zhu X, Dziegielewska B, Bachman KE, Ellenberger T, Ballin JD, Wilson GM, Tomkinson AE, MacKerell AD (2008) Identification and validation of human DNA ligase inhibitors using computer-aided drug design. J Med Chem 51(15):4553\u20134562. https:\/\/doi.org\/10.1021\/jm8001668","journal-title":"J Med Chem"},{"issue":"4","key":"10323_CR50","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1142\/S0219633608004155","volume":"7","author":"SJ Zhong","year":"2008","unstructured":"Zhong SJ, Mackerell AD (2008) Pose scaling: geometrical assessment of ligand binding poses. J Theor Comput Chem 7(4):833\u2013852. https:\/\/doi.org\/10.1142\/S0219633608004155","journal-title":"J Theor Comput Chem"},{"issue":"7","key":"10323_CR51","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1021\/acs.jcim.7b00153","volume":"57","author":"SS Ericksen","year":"2017","unstructured":"Ericksen SS, Wu HZ, Zhang HK, Michael LA, Newton MA, Hoffmann FM, Wildman SA (2017) Machine learning consensus scoring improves performance across targets in structure-based virtual screening. J Chem Inf Model 57(7):1579\u20131590. https:\/\/doi.org\/10.1021\/acs.jcim.7b00153","journal-title":"J Chem Inf Model"},{"issue":"25","key":"10323_CR52","doi-asserted-by":"publisher","first-page":"5100","DOI":"10.1021\/jm990352k","volume":"42","author":"PS Charifson","year":"1999","unstructured":"Charifson PS, Corkery JJ, Murcko MA, Walters WP (1999) Consensus scoring: a method for obtaining improved hit rates from docking databases of three-dimensional structures into proteins. J Med Chem 42(25):5100\u20135109. https:\/\/doi.org\/10.1021\/jm990352k","journal-title":"J Med Chem"},{"issue":"5","key":"10323_CR53","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1021\/ci010025x","volume":"41","author":"RX Wang","year":"2001","unstructured":"Wang RX, Wang SM (2001) How does consensus scoring work for virtual library screening? an idealized computer experiment. J Chem Inf Comp Sci 41(5):1422\u20131426. https:\/\/doi.org\/10.1021\/ci010025x","journal-title":"J Chem Inf Comp Sci"},{"issue":"22","key":"10323_CR54","doi-asserted-by":"publisher","first-page":"3658","DOI":"10.1093\/bioinformatics\/btx491","volume":"33","author":"D Lagorce","year":"2017","unstructured":"Lagorce D, Bouslama L, Becot J, Miteva MA, Villoutreix BO (2017) FAF-drugs4: free ADME-tox filtering computations for chemical biology and early stages drug discovery. Bioinformatics 33(22):3658\u20133660. https:\/\/doi.org\/10.1093\/bioinformatics\/btx491","journal-title":"Bioinformatics"},{"issue":"6","key":"10323_CR55","doi-asserted-by":"publisher","first-page":"2140","DOI":"10.1021\/ci700257y","volume":"47","author":"TJ Cheng","year":"2007","unstructured":"Cheng TJ, Zhao Y, Li X, Lin F, Xu Y, Zhang XL, Li Y, Wang RX, Lai LH (2007) Computation of octanol-water partition coefficients by guiding an additive model with knowledge. J Chem Inf Model 47(6):2140\u20132148. https:\/\/doi.org\/10.1021\/ci700257y","journal-title":"J Chem Inf Model"},{"issue":"1\u20133","key":"10323_CR56","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0169-409X(00)00129-0","volume":"23","author":"CA Lipinski","year":"1997","unstructured":"Lipinski CA, Lombardo F, Dominy BW, Feeney PJ (1997) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Del Rev 23(1\u20133):3\u201325. https:\/\/doi.org\/10.1016\/S0169-409X(00)00129-0","journal-title":"Adv Drug Del Rev"},{"issue":"7","key":"10323_CR57","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.1021\/jm901137j","volume":"53","author":"JB Baell","year":"2010","unstructured":"Baell JB, Holloway GA (2010) New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays. J Med Chem 53(7):2719\u20132740. https:\/\/doi.org\/10.1021\/jm901137j","journal-title":"J Med Chem"},{"key":"10323_CR58","unstructured":"Case D, Babin V, Berryman J, Betz R, Cai Q, Cerutti D, Cheatham Iii T, Darden T, Duke R, Gohlke H, Goetz A, Gusarov S, Homeyer N, Janowski P, Kaus J, Kolossv\u00e1ry I, ovalenko A, Lee T, LeGrand S, Luchko T, Luo R, Madej B, Merz K, Paesani F, Roe D, Roitberg A, Sagui C, Salomon-Ferrer R, Seabra G, Simmerling C, Smith W, Swails J, Walker R, Wang J, Wolf R, Wu X, Kollman P (2014) Amber 14. University of California, San Francisco. http:\/\/www.ambermd.org"},{"issue":"9","key":"10323_CR59","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1002\/Jcc.20035","volume":"25","author":"JM Wang","year":"2004","unstructured":"Wang JM, Wolf RM, Caldwell JW, Kollman PA, Case DA (2004) Development and testing of a general amber force field. J Comput Chem 25(9):1157\u20131174. https:\/\/doi.org\/10.1002\/Jcc.20035","journal-title":"J Comput Chem"},{"issue":"8","key":"10323_CR60","doi-asserted-by":"publisher","first-page":"3696","DOI":"10.1021\/acs.jctc.5b00255","volume":"11","author":"JA Maier","year":"2015","unstructured":"Maier JA, Martinez C, Kasavajhala K, Wickstrom L, Hauser KE, Simmerling C (2015) ff14SB: improving the accuracy of protein side chain and backbone parameters from ff99SB. J Chem Theory Comput 11(8):3696\u20133713. https:\/\/doi.org\/10.1021\/acs.jctc.5b00255","journal-title":"J Chem Theory Comput"},{"issue":"37","key":"10323_CR61","doi-asserted-by":"publisher","first-page":"9401","DOI":"10.1021\/ja981844+","volume":"120","author":"J Srinivasan","year":"1998","unstructured":"Srinivasan J, Cheatham TE, Cieplak P, Kollman PA, Case DA (1998) Continuum solvent studies of the stability of DNA, RNA, and phosphoramidateDNA helices. J Am Chem Soc 120(37):9401\u20139409. https:\/\/doi.org\/10.1021\/ja981844+","journal-title":"J Am Chem Soc"},{"key":"10323_CR62","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1146\/annurev.physchem.51.1.129","volume":"51","author":"D Bashford","year":"2000","unstructured":"Bashford D, Case DA (2000) Generalized born models of macromolecular solvation effects. Annu Rev Phys Chem 51:129\u2013152. https:\/\/doi.org\/10.1146\/annurev.physchem.51.1.129","journal-title":"Annu Rev Phys Chem"},{"issue":"1","key":"10323_CR63","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1021\/ci100275a","volume":"51","author":"TJ Hou","year":"2011","unstructured":"Hou TJ, Wang JM, Li YY, Wang W (2011) Assessing the performance of the MM\/PBSA and MM\/GBSA methods. 1. the accuracy of binding free energy calculations based on molecular dynamics simulations. J Chem Inf Model 51(1):69\u201382. https:\/\/doi.org\/10.1021\/ci100275a","journal-title":"J Chem Inf Model"},{"issue":"4","key":"10323_CR64","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1021\/ci8004429","volume":"49","author":"X Zhang","year":"2009","unstructured":"Zhang X, Li X, Wang R (2009) Interpretation of the binding affinities of PTP1B inhibitors with the MM-GB\/SA method and the X-score scoring function. J Chem Inf Model 49(4):1033\u20131048. https:\/\/doi.org\/10.1021\/ci8004429","journal-title":"J Chem Inf Model"},{"key":"10323_CR65","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.ymeth.2014.10.013","volume":"71","author":"A Vuorinen","year":"2015","unstructured":"Vuorinen A, Schuster D (2015) Methods for generating and applying pharmacophore models as virtual screening filters and for bioactivity profiling. Methods 71:113\u2013134. https:\/\/doi.org\/10.1016\/j.ymeth.2014.10.013","journal-title":"Methods"},{"issue":"1\u20132","key":"10323_CR66","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1002\/minf.200900071","volume":"29","author":"D Schuster","year":"2010","unstructured":"Schuster D, Waltenberger B, Kirchmair J, Distinto S, Markt P, Stuppner H, Rollinger JM, Wolber G (2010) Predicting cyclooxygenase inhibition by three-dimensional pharmacophoric profiling. part I: model generation, validation and applicability in ethnopharmacology. Mol Inform 29(1\u20132):75\u201386. https:\/\/doi.org\/10.1002\/minf.200900071","journal-title":"Mol Inform"},{"issue":"1","key":"10323_CR67","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1021\/ci990316u","volume":"40","author":"JW Godden","year":"2000","unstructured":"Godden JW, Xue L, Bajorath J (2000) Combinatorial preferences affect molecular similarity\/diversity calculations using binary fingerprints and tanimoto coefficients. J Chem Inf Comp Sci 40(1):163\u2013166. https:\/\/doi.org\/10.1021\/ci990316u","journal-title":"J Chem Inf Comp Sci"},{"key":"10323_CR68","unstructured":"Neubert A, Barnes D, Kwak Y-S, Nakajima K, Bebernitz GR, Coppola GM, Kirman L, Serrano-Wu MH, Stams T, Topiol SW, Vedananda TR, Wareing JR (2007) Organic arylthiadiazolidinetrione compounds as protein tyrosine phosphatase inhibitors and their preparation, pharmaceutical compositions and use in the treatment of diseases. Application: WO Patent WO 2007115058 A2,"},{"issue":"6","key":"10323_CR69","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.1021\/jm901090b","volume":"53","author":"AP Combs","year":"2010","unstructured":"Combs AP (2010) Recent advances in the discovery of competitive protein tyrosine phosphatase 1B inhibitors for the treatment of diabetes, obesity, and cancer. J Med Chem 53(6):2333\u20132344. https:\/\/doi.org\/10.1021\/jm901090b","journal-title":"J Med Chem"},{"issue":"9","key":"10323_CR70","doi-asserted-by":"publisher","first-page":"3314","DOI":"10.1021\/ct300418h","volume":"8","author":"BR Miller","year":"2012","unstructured":"Miller BR, McGee TD, Swails JM, Homeyer N, Gohlke H, Roitberg AE (2012) MMPBSA.py: an efficient program for end-state free energy calculations. J Chem Theory Comput 8(9):3314\u20133321. https:\/\/doi.org\/10.1021\/ct300418h","journal-title":"J Chem Theory Comput"},{"issue":"W1","key":"10323_CR71","doi-asserted-by":"publisher","first-page":"W443","DOI":"10.1093\/nar\/gkv315","volume":"43","author":"S Salentin","year":"2015","unstructured":"Salentin S, Schreiber S, Haupt VJ, Adasme MF, Schroeder M (2015) PLIP: fully automated protein-ligand interaction profiler. Nucleic Acids Res 43(W1):W443\u2013W447. https:\/\/doi.org\/10.1093\/nar\/gkv315","journal-title":"Nucleic Acids Res"}],"container-title":["Molecular Diversity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-021-10323-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11030-021-10323-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-021-10323-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,31]],"date-time":"2022-07-31T13:05:09Z","timestamp":1659272709000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11030-021-10323-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,16]]},"references-count":71,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["10323"],"URL":"https:\/\/doi.org\/10.1007\/s11030-021-10323-2","relation":{},"ISSN":["1381-1991","1573-501X"],"issn-type":[{"value":"1381-1991","type":"print"},{"value":"1573-501X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,16]]},"assertion":[{"value":"14 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}